Adherence to Hydroxychloroquine Lowers Lupus Mortality
07/01/2021 No Comments
A lupus cohort study from British Columbia, Canada has shown that medication adherence with hydroxychloroquine (HCQ) is associated with a 71% to 83% lower mortality.
A lupus cohort study from British Columbia, Canada has shown that medication adherence with hydroxychloroquine (HCQ) is associated with a 71% to 83% lower mortality.
However, analysis concluded that the use of Ivermectin in the management of COVID-19 infections is associated with faster time to viral clearance, shorter duration of hospitalisation, and higher rates of clinical recovery.”
Maintaining an average hydroxychloroquine whole blood level above 1,068 ng/mL significantly reduced the risk of thrombosis in adults with systemic lupus.